- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Potential of Cilostazol for Alzheimer’s Disease
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-22
DOI
10.3389/fphar.2019.00559
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
- (2018) Yu Gao et al. Current Alzheimer Research
- Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro
- (2018) Hidenobu Shozawa et al. NEUROSCIENCE LETTERS
- Cilostazol, a phosphodiesterase 3 inhibitor, activates proteasome-mediated proteolysis and attenuates tauopathy and cognitive decline
- (2018) Ari W. Schaler et al. Translational Research
- Emerging role of amyloid beta in stress response: Implication for depression and diabetes
- (2017) Maria Grazia Morgese et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
- (2017) Jos Prickaerts et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
- (2017) Reagon Karki et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons
- (2017) Gisele S. Seixas da Silva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alzheimer's disease as oligomeropathy
- (2017) Kenjiro Ono NEUROCHEMISTRY INTERNATIONAL
- Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers
- (2016) Tomohiro Umeda et al. BRAIN
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction
- (2016) Nozomi Hishikawa et al. Geriatrics & Gerontology International
- Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood–brain barrier
- (2016) Toshinori Takagi et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- High-speed atomic force microscopy reveals structural dynamics of amyloid β1–42aggregates
- (2016) Takahiro Watanabe-Nakayama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia
- (2015) Hideo Shichinohe et al. BRAIN RESEARCH
- Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity
- (2015) Ryoichi Takahashi et al. JOURNAL OF NEUROCHEMISTRY
- Effects of Cilostazol on Oxidative Stress, Systemic Cytokine Release, and Spinal Cord Injury in a Rat Model of Transient Aortic Occlusion
- (2014) Tunay Kurtoglu et al. ANNALS OF VASCULAR SURGERY
- Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2
- (2014) Shinichiro Uchiyama et al. CEREBROVASCULAR DISEASES
- Cilostazol improves lymphatic function by inducing proliferation and stabilization of lymphatic endothelial cells
- (2014) Takayuki Kimura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid
- (2014) Takakuni Maki et al. Annals of Clinical and Translational Neurology
- CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?
- (2014) William T. Hu et al. Annals of Clinical and Translational Neurology
- Attenuation of β-amyloid-induced tauopathy via activation of CK2α/SIRT1: Targeting for cilostazol
- (2013) Hye Rin Lee et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Recent Studies of Antioxidant Quinoline Derivatives
- (2013) M. Orhan Puskullu et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis
- (2013) Akihiko Taguchi et al. Psychogeriatrics
- Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: A pilot study
- (2012) Hirofumi Sakurai et al. Geriatrics & Gerontology International
- Phenolic Compounds Prevent Amyloid β-Protein Oligomerization and Synaptic Dysfunction by Site-specific Binding
- (2012) Kenjiro Ono et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation
- (2011) Sun Haeng Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia
- (2011) Yoshiki Hase et al. EXPERIMENTAL NEUROLOGY
- Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum
- (2011) Andreas Charidimou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The role of CREB signaling in Alzheimer’s disease and other cognitive disorders
- (2011) Carlos A. Saura et al. REVIEWS IN THE NEUROSCIENCES
- Cilostazol Reduces the Risk of Hemorrhagic Infarction After Administration of Tissue-Type Plasminogen Activator in a Murine Stroke Model
- (2011) Yukiko Kasahara et al. STROKE
- Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo
- (2010) Kazuhiro Nakaya et al. ATHEROSCLEROSIS
- Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases
- (2010) Won-Kyo Jung et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cilostazol prevents amyloid β peptide25-35-induced memory impairment and oxidative stress in mice
- (2010) Masayuki Hiramatsu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
- (2010) Yukito Shinohara et al. LANCET NEUROLOGY
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
- (2010) Viktor Lakics et al. NEUROPHARMACOLOGY
- Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia
- (2010) Y. Tanaka et al. NEUROSCIENCE
- A Combination Therapy of Donepezil and Cilostazol for Patients With Moderate Alzheimer Disease: Pilot Follow-Up Study
- (2009) Heii Arai et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Structure-neurotoxicity relationships of amyloid -protein oligomers
- (2009) K. Ono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cilostazol Inhibits Oxidative Stress–Induced Premature Senescence Via Upregulation of Sirt1 in Human Endothelial Cells
- (2008) Hidetaka Ota et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now